![N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide structure](/static/products/5984/5984-58-7.webp)
N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide
TL;DR: N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide (CAS 5984-58-7) is a chemical compound with molecular formula C22H24BrN5O2S and molecular weight 501.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide
Also Known As: N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide
| Molecular Formula | C22H24BrN5O2S |
|---|---|
| Molecular Weight | 501.08 g/mol |
| LogP | 5.45092 |
| Topological Polar Surface Area | 96.01 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Exact Mass | 501.0834 |
| Heavy Atoms | 31 |
| Complexity | 1071.3147 |
Chemical Identifiers
| CAS Number | 5984-58-7 |
|---|---|
| SMILES | CCC(C)C(C(=O)NC1=NN=C(S1)C2=CC(=CC=C2)Br)NC(=O)NC3=CC=CC(=C3)C |
Product Overview
N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide (CAS 5984-58-7), with molecular formula C22H24BrN5O2S and molecular weight 501.08 g/mol. IUPAC: N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide.
Chemical Property Profile of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide
Property Insights of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide
The XLogP value of 5.45092 indicates that N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 96.01 Ų falls within the moderate polarity range, balancing permeability and solubility for N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide. Following Lipinski's Rule of Five, N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide has 3 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide?
The CAS number of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide is 5984-58-7.
What is the molecular formula of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide?
The molecular formula of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide is C22H24BrN5O2S.
What is the molecular weight of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide?
The molecular weight of N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide is 501.08 g/mol.
Where can I buy N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide?
You can request a quote for N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide?
Yes, KEHONG BIO provides custom synthesis services for N-[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-2-[(3-methylphenyl)carbamoylamino]pentanamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.